back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-04 16:37 Tx date 2026-03-03 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+347 vol |
52,391 | |
| Filed 2026-03-04 16:37 Tx date 2026-03-03 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,203 vol |
52,044 | |
| Filed 2026-03-04 16:36 Tx date 2026-03-03 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+950 vol |
48,841 | |
| Filed 2026-03-04 16:36 Tx date 2026-03-03 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,138
+347 vol $17.69 each |
17,000 | |
| Filed 2026-03-04 16:36 Tx date 2026-03-03 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$56,629
+3,203 vol $17.68 each |
16,653 | |
| Filed 2026-03-04 16:35 Tx date 2026-03-03 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,788
+950 vol $17.67 each |
13,450 | |
| Filed 2025-12-08 18:54 Tx date 2025-12-03 |
$BHC
Bausch Health Companies Inc. |
Ross Sr., Thomas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80,500
-11,500 vol $7.00 each |
0 | |
| Filed 2025-05-28 16:31 Tx date 2025-05-27 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+20,338 vol |
47,891 | |
| Filed 2024-08-06 22:06 Tx date 2024-08-02 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+14,696 vol |
27,553 | |
| Filed 2024-07-02 19:00 Tx date 2022-05-05 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Ross Sr., Thomas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-07-02 19:00 Tx date 2022-05-05 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Ross Sr., Thomas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-21 15:34 Tx date 2016-03-08 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Ross Sr., Thomas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-15 18:14 Tx date 2016-03-08 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Ross Sr., Thomas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-23 12:58 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
150,016 | |
| Filed 2023-05-08 10:07 Tx date 2023-05-04 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,857 vol |
12,857 | |
| Filed 2023-04-27 16:52 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$214,000
+12,500 vol $17.12 each |
12,500 | |
| Filed 2023-04-27 16:52 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-27 16:51 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-214,000
-12,500 vol $17.12 each |
0 | |
| Filed 2022-06-29 13:09 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
120,811 | |
| Filed 2022-05-12 09:14 Tx date 2022-05-10 |
$BLCO
Bausch + Lomb Corporation |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,500 vol |
12,500 |